STEPS IN DIAGNOSIS OF CHRONIC IDIOPATHIC NEUTROPENIA: IS IT THE TIME FOR SERBIAN PATIENT REGISTRY?

Chronic idiopatic neutropenia - steps in diagnosis

  • Sanja Veličković
  • Miodrag Vučić
  • Nikola Stefanović
  • Filip Veličković
  • Eirini Mauroudi
  • Helen Papadaki Prof.dr
  • Aleksandra Krsto Catić-Đorđević Assistant Professor at Medical faculty University of Nis
Keywords: chronic idiopathic neutropenia, diagnostic approach, register

Abstract


Chronic neutropenia corresponds with absolute count of neutrophils below 1.8 × 109 /L in last three months. Besides, neutropenia that persists more than three months and in absence of underlying diseases, chemical components, irradiation, use of particular drugs, inflammation, is defined as chronic idiopathic neutropenia (CIN). There are three types of CIN - severe, moderate and mild, with or without extrahaematopoietic manifestations. The aim of this report was to define a stratified approach toward patient with hypothesis of CIN, including timely patient recognition with consequent follow-up and actions afterwards based on recommendation from EuNet INNOCHRON- European Network for Innovative Diagnosis and Treatment of Chronic Neutropenias. Case presented 40-year-old female who went in Hematology Department at University Clinical Center Nis for regular health condition and blood count control. Since she was 21, she has been following neutropenia, which occurred immediately after first childbirth. Laboratory parameters and peripheral blood smear was into physiological range. Performed immune assays excluded the immune background of neutropenia. In the next step, we excluded viral infections as a cause of neutropenia with particular serological tests. Also, a bone marrow puncture was performed with physiological results.
Chronic neutropenia can be associated with serious health complications. Similar to other European country we suggest to introduce defined approach of diagnose, registration and monitoring chronic neutropenia patients in Serbia throw Register.

Author Biography

Aleksandra Krsto Catić-Đorđević, Assistant Professor at Medical faculty University of Nis
Pharmacy

References

Bartels M, Murphy K, Rieter E, Bruin M. Understanding chronic neutropenia: life is short. Br J Haematol 2016; 172:157-69. [CrossRef] [PubMed]

Chan JL, Matarese G, Shetty GK, Raciti P, Kelesidis I, Aufiero D et al. Differential regulation of metabolic, neuroendocrine, and immune function by leptin in humans. Proc Natl Acad Sci U S A 2006;103:8481-6. [CrossRef] [PubMed]

Dale DC, Bolyard AA, Steele LA, Zeidler C, Welte K. Severe Chronic Neutropenia International Registry. Registries for study of nonmalignant hematological diseases: the example of the Severe Chronic Neutro-penia International Registry. Curr Opin Hematol 2020: 18-26. [CrossRef] [PubMed]

Dale DC, Bolyard AA. An update on the diagnosis and treatment of chronic idiopathic neutropenia. Curr Opin Hematol 2017;24:46-53. [CrossRef] [PubMed]

Dale DC, Bolyard AA. An update on the diagnosis and treatment of chronic idiopathic neutropenia. Curr Opin Hematol 2017;24:46-53. [CrossRef] [PubMed]

Dale DC. How I diagnose and treat neutropenia. Curr Opin Hematol 2016;23:1-4. [CrossRef] [PubMed]

De Filippo E, Marra M, Alfinito F, Di Guglielmo ML, Majorano P, Cerciello G et al. Hematological com-plications in anorexia nervosa. Eur J Clin Nutr 2016; 70:1305-8. [CrossRef] [PubMed]

Deordieva E, Shvets O, Voronin K, Maschan A, Welte K, Skokowa J et al. Nicotinamide (vitamin B3) treat-ment improves response to G-CSF in severe congeni-tal neutropenia patients. Br J Haematol 2020;192: 788-92. [CrossRef] [PubMed]

Gibson C, Berliner N. How we evaluate and treat neutropenia in adults. Blood 2014 21;124:1251-8. [CrossRef] [PubMed]

James RM, Kinsey SE. The investigation and mana-gement of chronic neutropenia in children. Arch Dis Child 2006;91:852-8. [CrossRef] [PubMed]

Kim TO, Despotovic JM. Primary and Secondary Immune Cytopenias: Evaluation and Treatment Approach in Children. Hematol Oncol Clin North Am 2019;33: 489-506. [CrossRef] [PubMed]

Matarese G, La Rocca C, Moon HS, Huh JY, Brinkoetter MT, Chou S et al.  Selective capacity of metreleptin administration to reconstitute CD4+ T-cell number in females with acquired hypoleptinemia. Proc Natl Acad Sci U S A 2013;110:818-27. [CrossRef] [PubMed]

Newburger PE, Dale DC. Evaluation and management of patients with isolated neutropenia. Semin Hematol 2013;50:198-206. [CrossRef] [PubMed]

Özkale M, Sipahi T. Hematologic and bone marrow changes in children with protein-energy malnutrition. Pediatr Hematol Oncol 2014;31:349-58. [CrossRef] [PubMed]

Palmblad J, Dufour C, Papadaki HA. How we diagnose neutropenia in the adult and elderly patient. Haema-tologica 2014;99:1130-3. [CrossRef] [PubMed]

Palmblad J, Nilsson CC, Höglund P, Papadaki HA. How we diagnose and treat neutropenia in adults. Expert Rev Hematol 2016;9:479-87. [CrossRef] [PubMed]

Papadaki HA, Mavroudi I, Almeida A, Bux J, Cichy J, Dale DC et al. Congenital and Acquired Chronic Neu-tropenias: Challenges, Perspectives and Implementa-tion of the EuNet-INNOCHRON Action. Hemasphere 2020;4:40. [CrossRef] [PubMed]

Papadaki HA, Pontikoglou C. Pathophysiologic mecha-nisms, clinical features and treatment of idiopathic neutropenia. Expert Rev Hematol 2008;1:217-29. [CrossRef] [PubMed]

Rodríguez-Benítez MV, Gámez-Belmonte R, Gil-Campos M, Hernández-Chirlaque C, Bouzas PR, Sánchez de Medina F et al. Premature Birth Infants Present Elevated Inflammatory Markers in the Meco-nium. Front Pediatr 2021;8:627475. [CrossRef] [PubMed]

Skokowa J, Dale DC, Touw IP, Zeidler C, Welte K. Severe congenital neutropenias. Nat Rev Dis Primers 2017;3:17032. [CrossRef] [PubMed]

Skokowa J, Welte K. Defective G-CSFR signaling pathways in congenital Neutropenia. Hematol Oncol Clin North Am 2013;27:75-88. [CrossRef] [PubMed]

Spurny M, Jiang Y, Sowah SA, Schübel R, Nonnen-macher T, Bertheau R,et al. Changes in Bone Marrow Fat upon Dietary-Induced Weight Loss. Nutrients 2020;12:1509. [CrossRef] [PubMed]

Tesfa D, Gelius T, Sander B, Kimby E, Fadeel B, Palmblad J et al. Lateonset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro) myelocyte stage of granulopoiesis. Med Oncol 2008;25:374-9. [CrossRef] [PubMed]

Xia J, Bolyard AA, Rodger E, Stein S, Aprikyan AA, Dale DC et al. Prevalence of mutations in ELANE, GFI1, HAX1, SBDS, WAS and G6PC3 in patients with severe congenital neutropenia. Br J Haematol 2009; 147:535-42. [CrossRef] [PubMed]

Zeidler C, Grote UA, Nickel A, Brand B, Carlsson G, Cortesão E et al. Outcome and management of pregnancies in severe chronic neutropenia patients by the European Branch of the Severe Chronic Neutro-penia International Registry. Haematologica 2014;99: 1395-402. [CrossRef] [PubMed]

Published
2022/04/12
Section
Case report